AP NEWS
ADVERTISEMENT
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Globe Newswire
Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Athira Pharma to Present at Upcoming Investor Conferences

May 26, 2021 GMT

- Jefferies Healthcare Conference
- Goldman Sachs 42nd Annual Global Healthcare Conference

BOTHELL, Wash., May 26, 2021 (GLOBE NEWSWIRE) -- Athira Pharma, Inc.  (NASDAQ: ATHA) (“Athira”), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration, today announced that Leen Kawas, Ph.D., President and Chief Executive Officer, will participate in a fireside chat and one-on-one investor meetings at the Jefferies Virtual Healthcare Conference to be held June 1-4, 2021 and the Goldman Sachs 42nd Annual Global Healthcare Conference to be held June 8-11, 2021.

Details on the presentations can be found below.

Jefferies Healthcare Conference
Date: Wednesday, June 2, 2021
Fireside chat time: at 4:30 PM ET
Webcast: Click Here

ADVERTISEMENT

Goldman Sachs 42nd Annual Global Healthcare Conference
Date: Tuesday, June 8, 2021
Fireside chat time: at 5:30 PM ET
Webcast: Click Here

A webcast of each presentation can be accessed from the Investors section of the Athira website at https://investors.athira.com/news-and-events/events-and-presentations. An archived replay of the webcast will be available for at least 30 days following the event.

About Athira Pharma, Inc.
Athira, headquartered in the Seattle area, is a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration. We aim to provide rapid cognitive improvement and alter the course of neurological diseases with our novel mechanism of action. Athira is currently advancing its lead therapeutic candidate, ATH-1017, a novel small molecule for Alzheimer’s and Parkinson’s dementia. For more information, visit  www.athira.com. You can also follow Athira on  FacebookLinkedIn  and @athirapharma on  Twitter  and  Instagram.

Investor & Media Contact:
Julie Rathbun
Julie.rathbun@athira.com
206-769-9219